Yukon T1D Support Network

We provide peer supports, education, and advocacy for Yukon citizens diagnosed with Type 1 Diabetes. [email protected]

[Yukon T1D Support Network @YukonT1D]

Q: What is the word for patient advocates that criticize patients?
A: Blocked
#PunchUpNotDown

[Yukon T1D Support Network @YukonT1D]

@YukonPatient @yukongov Ummm because we are already in the thick of advocacy work and cannot add anything to our plate?Punch up, not laterally or down

[Yukon T1D Support Network @YukonT1D]

Can attest to this article’s accuracy. @yukongov doesn’t appear to appreciate the significant training of an EA working w/small kids with #T1D and you can’t just put the child with the assistant together on day 1. “Here, EA, pls do a pump change.” “Here, EA, pls calculate IOB”🙄

[Jackie Hong @xjackiehong]

ICYMI: a Whitehorse mom says the education department has denied her five-year-old with Type 1 diabetes an educational assistant for kindergarten.

https://t.co/KAk7RRCUYW

[Yukon T1D Support Network @YukonT1D]

And that’s a wrap on #ENDO2024 We have learned SO much about better care for people living with #Type1diabetes and we are hopeful to see some of what we’ve learned implemented in the #Yukon @yukonhss

[Yukon T1D Support Network @YukonT1D]

Significantly increased odds of readmission within 3 months of hospital admission due to DKA. Study shows that it is critical to provide timely follow up care to patients living with #Type1Diabetes #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Retrospective study shows that off label GLP-1 agonists reduce A1c and basal insulin in certain persons with #T1D. @UMassD #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Insulin resistance in #T1D is present even with normal weight and with automated insulin delivery, so “people with T1D urgently need adjunctive therapies” @PBjornstadMD @UWMedicine #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Numerous risk factors contribute to persons w/ #T1D having a life expectancy reduced by 8-13 yrs @PBjornstadMD @UWMedicine #ENDO2024

[Yukon T1D Support Network @YukonT1D]

There is an entire building dedicated to growing transplant cells for people w/ #Type1Diabetes. What is needed now are safe immunosuppressive agents. ~Dr David M. Harlan @UMASS #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Why aren’t we doing more on #T1D islet transplant? Immunosuppressive agents prove toxic. Nephrotoxicity, infectious complications, malignancy. Also there exist insufficient islet supply. ~Dr David M. Harlan @UMASS #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Trial demonstrated that progression from Stage 2 to Stage 3 #T1D can be delayed w/ drug teplizumab~Dr Linda DiMeglio @rileychildren @IUSMDeptMed #ENDO2024

[Yukon T1D Support Network @YukonT1D]

30-60% of children in US present with DKA at #T1D diagnosis~Dr Linda DiMeglio @rileychildren @IUSMDeptMed #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Primary care docs should understand stages of T1D, methods of, and suggested frequency for metabolic monitoring ~Dr Linda DiMeglio @rileychildren @IUSMDeptMed #ENDO2024

[Yukon T1D Support Network @YukonT1D]

“Staging is the most seminal discovery in our world of #T1D research” ~Dr Sanjoy Dutta @JDRF

[Yukon T1D Support Network @YukonT1D]

The future of #T1D care is multiple drugs taken safely and conveniently to improve short and long term health ~Dr Sanjoy Dutta @JDRF

[Yukon T1D Support Network @YukonT1D]

Only 30% of adults with #T1D are reaching desired glycemic ranges ~ Dr Sanjoy Dutta

[Yukon T1D Support Network @YukonT1D]

Tzield (teplizumad, a monoclonal anti-CD3 antibody) delays clinical #T1D in Stage 2 and prolongs beta cell function in Stage 3 T1D. ~Dr Sanjoy Dutta @JDRF

[Yukon T1D Support Network @YukonT1D]

Dr Sanjoy Dutta, Chief Scientific Officer @JDRF on #Type1diabetes: “This disease is 365, 24hrs day, and is unforgiving of any mistake”

[Yukon T1D Support Network @YukonT1D]

Interesting study from @JohnsHopkinsDOM showing that insulin administered at least halfway through a meal reduces inpatient hypoglycaemia. #Type1Diabetes #ENDO2024

[Yukon T1D Support Network @YukonT1D]

Amazing work being done by Dr. Lara McHan @URMC_DeptMed @URMed_GCH is focused on developing comprehensive paediatric to adult transition care for youths living w/#Type1Diabetes Working toward transition policy commencing when #T1D patients 12-13 yrs. Excellent work! #ENDO2024